Anne Fedoroff

816 total citations
8 papers, 553 citations indexed

About

Anne Fedoroff is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Anne Fedoroff has authored 8 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Anne Fedoroff's work include Glioma Diagnosis and Treatment (5 papers), Cancer survivorship and care (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Anne Fedoroff is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer survivorship and care (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Anne Fedoroff collaborates with scholars based in United States. Anne Fedoroff's co-authors include Nicholas Butowski, Michael D. Prados, Andrew T. Parsa, Mitchel S. Berger, Jane Rabbitt, Kathleen R. Lamborn, Margaretta Page, Susan M. Chang, Rupa Parvataneni and Rebecca DeBoer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Anne Fedoroff

8 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Fedoroff United States 6 363 177 163 137 132 8 553
Robert Aiken United States 14 203 0.6× 224 1.3× 193 1.2× 74 0.5× 120 0.9× 36 575
Carole Ramirez France 9 203 0.6× 272 1.5× 217 1.3× 77 0.6× 103 0.8× 23 704
Jonathan B. Lamano United States 14 258 0.7× 135 0.8× 223 1.4× 125 0.9× 234 1.8× 23 653
Iyad Alnahhas United States 10 250 0.7× 128 0.7× 117 0.7× 124 0.9× 34 0.3× 34 497
Meera Nandhabalan United Kingdom 5 242 0.7× 287 1.6× 91 0.6× 84 0.6× 41 0.3× 7 557
Mariza Daras United States 13 153 0.4× 168 0.9× 175 1.1× 150 1.1× 55 0.4× 38 479
Shiao-Pei Weathers United States 12 237 0.7× 65 0.4× 179 1.1× 105 0.8× 102 0.8× 18 400
Michael Salacz United States 9 168 0.5× 112 0.6× 101 0.6× 90 0.7× 53 0.4× 20 469
Hisashi Hatano Japan 8 183 0.5× 135 0.8× 112 0.7× 108 0.8× 44 0.3× 13 365
Lucia Cuppini Italy 10 335 0.9× 130 0.7× 116 0.7× 66 0.5× 98 0.7× 17 549

Countries citing papers authored by Anne Fedoroff

Since Specialization
Citations

This map shows the geographic impact of Anne Fedoroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Fedoroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Fedoroff more than expected).

Fields of papers citing papers by Anne Fedoroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Fedoroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Fedoroff. The network helps show where Anne Fedoroff may publish in the future.

Co-authorship network of co-authors of Anne Fedoroff

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Fedoroff. A scholar is included among the top collaborators of Anne Fedoroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Fedoroff. Anne Fedoroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Crane, Courtney A., Seunggu J. Han, Brian Ahn, et al.. (2012). Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein. Clinical Cancer Research. 19(1). 205–214. 150 indexed citations
2.
Parvataneni, Rupa, Mei‐Yin C. Polley, Kathleen R. Lamborn, et al.. (2011). Identifying the needs of brain tumor patients and their caregivers. Journal of Neuro-Oncology. 104(3). 737–744. 33 indexed citations
3.
Parsa, A., Courtney A. Crane, Seunggu J. Han, et al.. (2011). Autologous heat shock protein vaccine (HSPPC-96) for patients with recurrent glioblastoma (GBM): Results of a phase II multicenter clinical trial with immunological assessments.. Journal of Clinical Oncology. 29(15_suppl). 2565–2565. 5 indexed citations
4.
Butowski, Nicholas, Kathleen R. Lamborn, Susan M. Chang, et al.. (2009). Phase II and pharmacogenomics study of enzastaurin plus temozolomide and radiation therapy in patients with glioblastoma multiforme or gliosarcoma. Journal of Clinical Oncology. 27(15_suppl). 2020–2020. 3 indexed citations
5.
Liu, Raymond, Karla Solheim, Mei‐Yin C. Polley, et al.. (2008). Quality of life in low-grade glioma patients receiving temozolomide. Neuro-Oncology. 11(1). 59–68. 60 indexed citations
6.
Butowski, Nicholas, Kathleen R. Lamborn, Michaelyn A. Page, et al.. (2008). Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS). Journal of Clinical Oncology. 26(15_suppl). 3559–3559. 7 indexed citations
7.
Prados, Michael D., Susan M. Chang, Nicholas Butowski, et al.. (2008). Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma. Journal of Clinical Oncology. 27(4). 579–584. 286 indexed citations
8.
Parsa, Andrew T., Courtney A. Crane, Sean Wilson, et al.. (2007). Autologous tumor derived gp96 evokes a tumor specific immune response in recurrent glioma patients that correlates with clinical response to therapy. Molecular Cancer Therapeutics. 6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Aiken Breakdown of academic impact, for papers by Carole Ramirez Breakdown of academic impact, for papers by Jonathan B. Lamano Breakdown of academic impact, for papers by Iyad Alnahhas Breakdown of academic impact, for papers by Meera Nandhabalan Breakdown of academic impact, for papers by Mariza Daras Breakdown of academic impact, for papers by Shiao-Pei Weathers Breakdown of academic impact, for papers by Michael Salacz Breakdown of academic impact, for papers by Hisashi Hatano Breakdown of academic impact, for papers by Lucia Cuppini
Rankless by CCL
2026